[go: up one dir, main page]

WO2003009856A1 - Emollient cervical - Google Patents

Emollient cervical Download PDF

Info

Publication number
WO2003009856A1
WO2003009856A1 PCT/JP2002/007554 JP0207554W WO03009856A1 WO 2003009856 A1 WO2003009856 A1 WO 2003009856A1 JP 0207554 W JP0207554 W JP 0207554W WO 03009856 A1 WO03009856 A1 WO 03009856A1
Authority
WO
WIPO (PCT)
Prior art keywords
softener
cervical
weight
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2002/007554
Other languages
English (en)
Japanese (ja)
Inventor
Akira Asari
Hitoshi Kurihara
Shinichi Nakajima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seikagaku Corp
Original Assignee
Seikagaku Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Corp filed Critical Seikagaku Corp
Priority to JP2003515248A priority Critical patent/JP4312048B2/ja
Publication of WO2003009856A1 publication Critical patent/WO2003009856A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

L'invention concerne un émollient cervical contenent comme principe actif soit un acide hyaluronique de poids moléculaire moyen en poids de 600 000 à 3 100 000 soit un sel pharmaceutiquement acceptable dudit acide.
PCT/JP2002/007554 2001-07-27 2002-07-25 Emollient cervical Ceased WO2003009856A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003515248A JP4312048B2 (ja) 2001-07-27 2002-07-25 子宮頚管軟化剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001227062 2001-07-27
JP2001-227062 2001-07-27

Publications (1)

Publication Number Publication Date
WO2003009856A1 true WO2003009856A1 (fr) 2003-02-06

Family

ID=19059777

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/007554 Ceased WO2003009856A1 (fr) 2001-07-27 2002-07-25 Emollient cervical

Country Status (2)

Country Link
JP (1) JP4312048B2 (fr)
WO (1) WO2003009856A1 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016559A1 (fr) * 1996-10-15 1998-04-23 Toray Industries, Inc. Agent de maturation des canaux cervicaux

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016559A1 (fr) * 1996-10-15 1998-04-23 Toray Industries, Inc. Agent de maturation des canaux cervicaux

Also Published As

Publication number Publication date
JP4312048B2 (ja) 2009-08-12
JPWO2003009856A1 (ja) 2004-11-11

Similar Documents

Publication Publication Date Title
WO2003037860A3 (fr) Analogues de purine presentant une activite inhibitrice de hsp90
WO2005065645A3 (fr) Formulations de donepezil
WO2003048081A3 (fr) Glycinamides en tant qu'inhibiteurs du facteur xa
WO2002002525A3 (fr) N-ureidoheterocycloaklyl-piperidines utilises comme modulateurs de l'activite du recepteur de la chimiokine
WO2001072728A3 (fr) Nouveaux derives de piperazine
WO2003000187A3 (fr) Nouvelles pyrazolo-pyrimidines et pyrrolo-pyrimidines et leur utilisation
WO2005041653A3 (fr) Combinaisons d'agents actifs synergiques fongicides
CA2444587A1 (fr) Compositions pharmaceutiques a faible concentration de chlorhydrate de polyallylamine
WO2003053359A3 (fr) 1,3-bis-(phenyl-substitue)-2-propyne-1-ones et leur utilisation pour le traitement d'affections
WO2006002840A8 (fr) Formulations de suspensions aerosol contenant tg 227 ea ou tg 134 a en tant qu'agent propulseur
CA2450093A1 (fr) Polymorphe stable de flibanserine, procede de preparation associe et utilisation dudit polymorphe dans la preparation de medicaments
WO2002088100A3 (fr) 3-piperidinopropiophenones dopees et produits pharmaceutiques contenant ces composes
WO2000027850A3 (fr) Antagonistes de recepteurs du crf et methodes associees
HK1046631A1 (zh) 含有酮替芬的眼药组合物
JP2000159790A5 (fr)
EP1440691A3 (fr) Traitement des troubles neurotiques
WO2003053971A8 (fr) Antiviraux a base de pyridoquinoxaline
WO2001098270A3 (fr) N-ureidoalkyl-piperidines utiles comme modulateurs de l'activite du recepteur de chimiokine
WO2003024933A1 (fr) Derive d'acide 2-phenyle-3-heteroarylpropionique ou son sel et medicaments le contenant
WO2001098269A3 (fr) N-ureidoalkyl-piperidines utiles comme modulateurs de l'activite du recepteur de chimiokine
WO2003066022A3 (fr) Preparation pharmaceutique stable pour le traitement des troubles gastro-intestinaux
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
WO2003024941A1 (fr) Composes de naphtalene et leur utilisation comme medicament
CA2399709A1 (fr) Utilisation d'acide 2-methyl-thiazolidin-2,4-dicarboxylique (2-mtdc) et/ou de ses sels physiologiquement compabibles pour le traitement et/ou la prevention de cancers
WO2004048381A3 (fr) Nouveaux composes de pyrazoloazepine utilises en tant qu'agents pharmaceutiques

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003515248

Country of ref document: JP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase